5α-reductase in human embryonic kidney cell line HEK293: Evidence for type II enzyme expression and activity

Molecular and Cellular Biochemistry

Volumn 270, Issue 1-2, 2005, Pages 201-208

  Panter, Baerbel U ^a   Jose, Joachim ^a   Hartmann, Rolf W ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

3 oxo 5 alpha steroid 4 dehydrogenase (5 reductase); Benign prostatic hyperplasia; Dihydrotestosterone; Human embryonic kidney cell line HEK293; Prostate cancer

Indexed keywords

ANDROSTANEDIONE; ANDROSTENEDIONE; MESSENGER RNA; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; ANDROSTANE-3,17-DIONE; CHOLESTENONE 5ALPHA REDUCTASE; DRUG DERIVATIVE; ETIOCHOLANOLONE; OXIDOREDUCTASE; PRIMER DNA; RECOMBINANT PROTEIN;

ARTICLE; CELL LINE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EMBRYO; EMBRYO CELL; ENZYME ACTIVITY; ENZYME MECHANISM; GENE IDENTIFICATION; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INCUBATION TIME; KIDNEY CELL; NONHUMAN; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPARATION TECHNIQUE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL NUCLEUS; CHEMISTRY; ENZYMOLOGY; KIDNEY; METABOLISM; MICROSOME; TIME;

ORYCTOLAGUS CUNICULUS;

ANDROSTENEDIONE; ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL NUCLEUS; CHOLESTENONE 5 ALPHA-REDUCTASE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA PRIMERS; ETIOCHOLANOLONE; HUMANS; KIDNEY; MICROSOMES; OXIDOREDUCTASES; RABBITS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSFECTION;

EID: 15844402158     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-4508-8     Document Type: Article

References (19)

1. Russell DW, Wilson JD: Steroid 5α-reductase: Two genes/two enzymes. Annu Rev Biochem 63: 25-61, 1994 1:CAS:528:DyaK2MXitlCitQ%3D%3D
2. Akinola LA, Poutanen M, Vihko R: Cloning of rat 17beta-hydroxysteroide dehydrogenase type 2 and characterization of tissue distribution and catalytic activity of rat type 1 and type 2 enzymes. Endocrinology 137: 1572-1579, 1996
3. Sherbert DP, Tiosano D, Kwist KM, Hochberg Z, Auchus RJ: CYP17 Mutation E305G causes isolated 17,20-Lyase Deficiency by selectively altering substrate binding. J Biol Chem 278: 48563-48569, 2003
4. Reichert W, Hartmann RW, Jose J: Stable expression of the human 5alpha-reductase isoenzymes type I and type II in HEK293 cells to identify dual and selective inhibitors. J Enzyme Inhib 16: 47-53, 2001
5. Reichert W, Jose J, Hartmann RW: 5alpha-reductase in intact DU145 cells: Evidence for isozyme I and evaluation of novel inhibitors. Arch Pharm Med Chem 333: 201-204, 2000
6. Bayne EK, Flanagan J, Einstein M, Ayala J, Chang B, Azzolina B, Whiting DA, Mumford RA, Thiboutot D, Singer II, Harris G: Immunohistochemical localization of types 1 and 2 5alpha-reductase in human scalp. Brit J Derm 141: 481-491, 1999
7. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci 76 (9): 4350-4354, 1979 1:CAS:528:DyaE1MXmtVKltLw%3D
8. Matsuzaki K, Arai T, Inumaru T, Mihori M, Momose T, Sano M, Koide K, Shimizu N: Androgen metabolism in cultured rat renal inner medullary collecting duct (IMCD) cells. Steroids, 63: 105-110, 1998
9. Hartmann RW, Hector M, Haidar S, Ehmer PB, Reichert W, Jose J: Synthesis and Evaluation of Novel steroidal oxime inhibitors of P450 17 (17 alpha-hydroxylase/C17-20-Lyase) and 5 alpha-reductase types 1 and 2. J Med Chem 43: 4266-4277, 2000
10. Reichert W, Michel A, Hartmann RW, Jose J: Stable expression of human 5alpha-reductase type II in COS1 cells due to chromosomal gene integration: A novel tool for inhibitor identification. J Steroid Biochem Mol Biol 78: 275-284, 2001
11. Issa S, Schnabel D, Feix M, Wolf L, Schaefer HE, Russell DW, Schweikert HU: Human osteoblast-like cells express predominantly steroid 5α-reductase type I. J Clin Endocrinol Metab 87: 5401-5407, 2002
12. Quinkler M, Bumke-Vogt C, Meyer B, Bähr V, Oelkers W, Diederich S: The human kidney is a progesterone-metabolizing and androgen-producing organ. J Clin Endocrinol Metab 88: 2803-2809, 2003
13. Quemener E, Amet Y, Fournier G, Di Stefano S, Abalain JH, Floch HH, Glycosylated nature of testosterone 5 alpha-reductase 2 purified from human prostate. Biochem Biophys Res Commun 205: 269-274, 1994
14. Quemener E, Amet Y, Fournier G, Di Stefano S, Fournier G, Floch HH, Abalain JH Purification of testosterone 5 alpha-reductase from human prostate by a four-step chromatographic procedure. Steroids 59: 712-718, 1994
15. Nielsen H, Krogh A: Prediction of signal peptides and signal anchors by a hidden Markov model. Proceedings of the Sixth International Conference on Intelligent Systems for Molecular Biology (ISMB 6) AAAI Press, Menlo Park, California 122-130, 1998
16. Schatz G, Dobberstein B: Common principles of protein translocation across membranes. Science 271: 1519-1526, 1996
17. Aumueller G, Eicheler W, Renneberg H, Adermann K, Vilja P, Forssmann WG: Immunocytochemical evidence for differential subcellular localization of 5 alpha-reductase isoenzymes in human tissues. Acta Anat 156: 241-252, 1996
18. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW: Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin Invest 92: 903-910, 1993 1:CAS:528:DyaK2cXhtVaqtLw%3D
19. Dick IM, Liu J, Glenenning P, Prince RL: Estrogen and androgen regulation of plasma membrane calcium pump activity in immortalized distal tubule kidney cells. Mol Cell Endocrinol 212: 11-18, 2003